These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2143865)
1. In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody. Ferran C; Bluestone J; Bach JF; Chatenoud L Transplant Proc; 1990 Aug; 22(4):1922-3. PubMed ID: 2143865 [No Abstract] [Full Text] [Related]
2. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Ferran C; Sheehan K; Dy M; Schreiber R; Merite S; Landais P; Noel LH; Grau G; Bluestone J; Bach JF Eur J Immunol; 1990 Mar; 20(3):509-15. PubMed ID: 2138557 [TBL] [Abstract][Full Text] [Related]
3. Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. Alegre M; Depierreux M; Florquin S; Najdovski T; Vandenabeele P; Abramowicz D; Leo O; Deschodt-Lanckman M; Goldman M Transplant Proc; 1990 Aug; 22(4):1920-1. PubMed ID: 2143864 [No Abstract] [Full Text] [Related]
4. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway. Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent activation of murine T cells following in vivo administration of anti-murine CD3. Ellenhorn JD; Hirsch R; Hartley JP; Bluestone JA Transplant Proc; 1989 Feb; 21(1 Pt 1):1013-4. PubMed ID: 2523110 [No Abstract] [Full Text] [Related]
6. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Woodle ES; Thistlethwaite JR; Jolliffe LK; Ghobrial I; Fuccello AJ; Stuart FP; Bluestone JA Transplant Proc; 1991 Feb; 23(1 Pt 1):81-2. PubMed ID: 1824999 [No Abstract] [Full Text] [Related]
7. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation. Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817 [TBL] [Abstract][Full Text] [Related]
8. [T lymphocyte activation induced in vivo in different strains of mice after injection of anti-CD3 antibodies: prevention by an anti- TNF antibody]. Ferran C Nephrologie; 1993; 14(1):23-4. PubMed ID: 8502345 [No Abstract] [Full Text] [Related]
9. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507 [TBL] [Abstract][Full Text] [Related]
10. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex. Schlitt HJ; Schwinzer R; Wonigeit K Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121 [No Abstract] [Full Text] [Related]
11. [T lymphocyte activation induced in vivo by the first injection of OKT3 monoclonal antibodies]. Chatenoud L; Ferran C; Reuter A; Legendre C; Gevaert Y; Kreis H; Franchimont P; Bach JF C R Acad Sci III; 1988; 307(19):833-6. PubMed ID: 3146414 [TBL] [Abstract][Full Text] [Related]
12. In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growth. Hirsch R; Ellenhorn JD; Bluestone JA Princess Takamatsu Symp; 1988; 19():237-43. PubMed ID: 2978618 [TBL] [Abstract][Full Text] [Related]
14. Suppression of antibody synthesis by CD4+ T cell clones and normal T cells stimulated with monoclonal anti-CD3 antibody. Silver LS; Scott DW; Quill H J Immunol; 1989 Dec; 143(11):3448-54. PubMed ID: 2573633 [TBL] [Abstract][Full Text] [Related]
15. Nakahara memorial lecture. Regulation of T lymphocyte responses: interactions among receptors. Fitch F; Gajewski T; Nau G; Schell S; Otten G Princess Takamatsu Symp; 1988; 19():15-27. PubMed ID: 2978617 [TBL] [Abstract][Full Text] [Related]
16. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156 [TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor activity of anti-CD3-induced activated killer cells. Yun YS; Hargrove ME; Ting CC Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087 [TBL] [Abstract][Full Text] [Related]
18. Suppression of the humoral response to anti-CD3 mAB by pretreatment with anti-CD4 mAB. Hirsch R; Chatenoud L; Gress RE; Bach JF; Sachs DH; Bluestone JA Transplant Proc; 1989 Feb; 21(1 Pt 1):1015-6. PubMed ID: 2523111 [No Abstract] [Full Text] [Related]
19. The use of an anti-CD3 priming dose to enhance the immunosuppressive potency of monoclonal and polyclonal T-cell antisera. Sherburne CG; Onyekaba CO; Condie RM Transplant Proc; 1991 Feb; 23(1 Pt 1):626-9. PubMed ID: 1824996 [No Abstract] [Full Text] [Related]
20. Cross-linking of Lyt-2 (CD8) to the T cell antigen receptor optimally activates T lymphocytes. Boyce NW; Eichmann K Transplant Proc; 1989 Feb; 21(1 Pt 1):133-7. PubMed ID: 2495596 [No Abstract] [Full Text] [Related] [Next] [New Search]